Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC Offers Its Take On Public Reporting Of Physician Ties To Industry

This article was originally published in The Gray Sheet

Executive Summary

With a bill still pending on Capitol Hill that would require device and drug companies to publicly report financial relationships with physicians, independent advisors to Congress gave the issue further prominence last week

You may also be interested in...



MedPAC Presents Policy Options For Reporting Physicians’ Ties To Industry

With legislation pending on public reporting of physicians' ties to industry, a group of independent advisors to Congress presented an early blueprint for a federal reporting system that could inform the final version of the bill

MedPAC Presents Policy Options For Reporting Physicians’ Ties To Industry

With legislation pending on public reporting of physicians' ties to industry, a group of independent advisors to Congress presented an early blueprint for a federal reporting system that could inform the final version of the bill

Medical Schools Take Stand Against Industry Gifts While AMA Sits Out Debate

Medical schools and teaching hospitals should prohibit physicians, faculty, residents and students from taking gifts and services from device and drug companies, the Association of American Medical Colleges urged its members June 19

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026253

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel